The possibilities of therapy of patients with metastatic colorectal cancer with <i>BRAF</i> V600E mutation. Clinical cases

Mutation in the BRAF V600E gene in metastatic colorectal cancer (CRC) occurs in 510% of cases and is a significant problem due to the aggressive course and extremely unfavorable prognosis. In recent years, new treatment options for BRAF mutated CRC have been emerging, for example, combinations of BR...

Full description

Bibliographic Details
Main Authors: Elizaveta M. Polyanskaya, Mikhail I. Fedyanin
Format: Article
Language:Russian
Published: IP Habib O.N. 2023-05-01
Series:Современная онкология
Subjects:
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/115076/pdf